A soluble form of Siglec-9 provides a resistance against Group B Streptococcus (GBS) infection in transgenic mice.
A soluble form of Siglec-9 provides a resistance against Group B Streptococcus (GBS) infection in transgenic mice.
复制标题
DOI：
10.1016/j.micpath.2016.08.014
复制
发表时间：
2016-10
影响因子：
3.8
通讯作者：
M. Saito;Sayo Yamamoto;K. Ozaki;Y. Tomioka;Haruka Suyama;M. Morimatsu;K. Nishijima;S. Yoshida;E. Ono
中科院分区：
文献类型：
--
作者：
M. Saito;Sayo Yamamoto;K. Ozaki;Y. Tomioka;Haruka Suyama;M. Morimatsu;K. Nishijima;S. Yoshida;E. Ono
